{"id":2894,"date":"2024-10-11T06:39:07","date_gmt":"2024-10-11T06:39:07","guid":{"rendered":"https:\/\/vichsec.org\/guidline\/environmental-impact-assessment-eias-for-veterinary-medicinal-products-vmps-phase-ii\/"},"modified":"2024-10-23T13:58:30","modified_gmt":"2024-10-23T13:58:30","slug":"environmental-impact-assessment-eias-for-veterinary-medicinal-products-vmps-phase-ii","status":"publish","type":"guideline","link":"https:\/\/vichsec.org\/fr\/guidline\/environmental-impact-assessment-eias-for-veterinary-medicinal-products-vmps-phase-ii\/","title":{"rendered":"\u00c9valuation de l\u2019impact environnemental (EIE) des m\u00e9dicaments v\u00e9t\u00e9rinaires &#8211; Phase II"},"content":{"rendered":"<p>VICH GL38 (\u00c9cotoxicit\u00e9 &#8211; Phase II) Octobre 2004 &#8211; Mise en \u0153uvre en octobre 2005<\/p>\n","protected":false},"menu_order":98,"template":"","meta":[],"guideline_category":[234],"class_list":["post-2894","guideline","type-guideline","status-publish","hentry","guideline_category-pharmaceuticals-pharma-safety-environmental-safety-fr"],"_links":{"self":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline\/2894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/types\/guideline"}],"wp:attachment":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/media?parent=2894"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline_category?post=2894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}